Hepatocellular carcinoma and sorafenib: too many resistance mechanisms?

被引：77
|
作者：
Berasain, Carmen [1 ]
机构：
[1] Univ Navarra, CIMA, Div Hepatol & Gene Therapy, Pamplona 31008, Spain
来源：
GUT | 2013年 / 62卷 / 12期
关键词：
Drug Resistance; Gene Targeting; Hepatocellular Carcinoma; Liver; Molecular Carcinogenesis; CELLS;
D O I：
10.1136/gutjnl-2013-304564
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1674 / 1675
页数：2
相关论文
共 50 条
  • [41] Sorafenib in advanced hepatocellular carcinoma
    Sauerbruch, T.
    Gonzalez-Carmona, A. M.
    Nitschmann, S.
    INTERNIST, 2009, 50 (11): : 1290 - 1292
  • [42] Sorafenib for the treatment of hepatocellular carcinoma
    Woerns, Marcus Alexander
    Galle, Peter Robert
    HEPATIC ONCOLOGY, 2014, 1 (02) : 189 - 204
  • [43] Sorafenib in advanced hepatocellular carcinoma
    Llovet, Josep M.
    Ricci, Sergio
    Mazzaferro, Vincenzo
    Hilgard, Philip
    Gane, Edward
    Blanc, Jean-Frederic
    Cosme de Oliveira, Andre
    Santoro, Armando
    Raoul, Jean-Luc
    Forner, Alejandro
    Schwartz, Myron
    Porta, Camillo
    Zeuzem, Stefan
    Bolondi, Luigi
    Greten, Tim F.
    Galle, Peter R.
    Seitz, Jean-Francois
    Borbath, Ivan
    Haussinger, Dieter
    Giannaris, Tom
    Shan, Minghua
    Moscovici, Marius
    Voliotis, Dimitris
    Bruix, Jordi
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (04): : 378 - 390
  • [44] Sorafenib: A Review in Hepatocellular Carcinoma
    Keating, Gillian M.
    TARGETED ONCOLOGY, 2017, 12 (02) : 243 - 253
  • [45] Sorafenib and radiotherapy in hepatocellular carcinoma
    Cihan, Y.
    ARCHIVES OF HELLENIC MEDICINE, 2020, 37 (03): : 418 - 419
  • [46] Hepatocellular carcinoma treated with sorafenib
    Han, G.
    Zhao, Y.
    Qi, X.
    Fan, D.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 34 (11-12) : 1347 - 1348
  • [47] Sorafenib for Advanced Hepatocellular Carcinoma
    Shingina, Alexandra
    Hashim, ALMoutaz
    Haque, Mazhar
    Suen, Michael W.
    Yoshida, Eric M.
    Gill, Sharlene
    Weiss, Alan
    GASTROENTEROLOGY, 2012, 142 (05) : S42 - S42
  • [48] Pregnane X receptor mediates sorafenib resistance in advanced hepatocellular carcinoma
    Feng, Fan
    Jiang, Qiyu
    Cao, Shuang
    Cao, Yu
    Li, Ruisheng
    Shen, Lijun
    Zhu, Hua
    Wang, Tao
    Sun, Lijun
    Liang, Erguang
    Sun, Huiwei
    Chai, Yantao
    Li, Xiaojuan
    Liu, Genyan
    Yang, Ruichang
    Yang, Zhi
    Yang, Yongping
    Xin, Shaojie
    Li, Bo-an
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2018, 1862 (04): : 1017 - 1030
  • [49] Inhibition of autophagy reverses the resistance to sorafenib induced by hypoxia in hepatocellular carcinoma
    Kogure, Takayuki
    Kondo, Yasuteru
    Inoue, Jun
    Nakagome, Yu
    Wakui, Yuta
    Morosawa, Tatsuki
    Fujisaka, Yasuyuki
    Umetsu, Teruyuki
    Shimosegawa, Tooru
    HEPATOLOGY, 2015, 62 : 1155A - 1156A
  • [50] Expression of Keratin 19 in advanced hepatocellular carcinoma and resistance to sorafenib treatment
    Wen, X.
    Xu, X.
    TRANSPLANTATION, 2019, 103 (08) : 62 - 62
12345